Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency
Curr Vasc Pharmacol. 2023 Nov 13. doi: 10.2174/0115701611269162231106042956. Online ahead of print.ABSTRACTGrowth hormone (GH) and insulin-like growth factor 1 (IGF-1) are increasingly recognised for their role in cardiovascular (CV) physiology. The GH-IGF-1 axis plays an essential role in the development of the CV system as well as in the complex molecular network that regulates cardiac and endothelial structure and function. A considerable correlation between GH levels and CV mortality exists even among individuals in the general population without a notable deviation in the GHIGF- 1 axis functioning. In addition, over t...
Source: Current Vascular Pharmacology - November 14, 2023 Category: Drugs & Pharmacology Authors: Herman R Janez A Mikhailidis Dp Poredos P Blinc A Sabovic M Bajuk Studen K Schernthaner Gh Anagnostis P Antignani Pl Jensterle M Source Type: research
Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency
Curr Vasc Pharmacol. 2023 Nov 13. doi: 10.2174/0115701611269162231106042956. Online ahead of print.ABSTRACTGrowth hormone (GH) and insulin-like growth factor 1 (IGF-1) are increasingly recognised for their role in cardiovascular (CV) physiology. The GH-IGF-1 axis plays an essential role in the development of the CV system as well as in the complex molecular network that regulates cardiac and endothelial structure and function. A considerable correlation between GH levels and CV mortality exists even among individuals in the general population without a notable deviation in the GHIGF- 1 axis functioning. In addition, over t...
Source: Current Vascular Pharmacology - November 14, 2023 Category: Drugs & Pharmacology Authors: Herman R Janez A Mikhailidis Dp Poredos P Blinc A Sabovic M Bajuk Studen K Schernthaner Gh Anagnostis P Antignani Pl Jensterle M Source Type: research
Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency
Curr Vasc Pharmacol. 2023 Nov 13. doi: 10.2174/0115701611269162231106042956. Online ahead of print.ABSTRACTGrowth hormone (GH) and insulin-like growth factor 1 (IGF-1) are increasingly recognised for their role in cardiovascular (CV) physiology. The GH-IGF-1 axis plays an essential role in the development of the CV system as well as in the complex molecular network that regulates cardiac and endothelial structure and function. A considerable correlation between GH levels and CV mortality exists even among individuals in the general population without a notable deviation in the GHIGF- 1 axis functioning. In addition, over t...
Source: Current Vascular Pharmacology - November 14, 2023 Category: Drugs & Pharmacology Authors: Herman R Janez A Mikhailidis Dp Poredos P Blinc A Sabovic M Bajuk Studen K Schernthaner Gh Anagnostis P Antignani Pl Jensterle M Source Type: research
Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency
Curr Vasc Pharmacol. 2023 Nov 13. doi: 10.2174/0115701611269162231106042956. Online ahead of print.ABSTRACTGrowth hormone (GH) and insulin-like growth factor 1 (IGF-1) are increasingly recognised for their role in cardiovascular (CV) physiology. The GH-IGF-1 axis plays an essential role in the development of the CV system as well as in the complex molecular network that regulates cardiac and endothelial structure and function. A considerable correlation between GH levels and CV mortality exists even among individuals in the general population without a notable deviation in the GHIGF- 1 axis functioning. In addition, over t...
Source: Current Vascular Pharmacology - November 14, 2023 Category: Drugs & Pharmacology Authors: Herman R Janez A Mikhailidis Dp Poredos P Blinc A Sabovic M Bajuk Studen K Schernthaner Gh Anagnostis P Antignani Pl Jensterle M Source Type: research
Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency
Curr Vasc Pharmacol. 2023 Nov 13. doi: 10.2174/0115701611269162231106042956. Online ahead of print.ABSTRACTGrowth hormone (GH) and insulin-like growth factor 1 (IGF-1) are increasingly recognised for their role in cardiovascular (CV) physiology. The GH-IGF-1 axis plays an essential role in the development of the CV system as well as in the complex molecular network that regulates cardiac and endothelial structure and function. A considerable correlation between GH levels and CV mortality exists even among individuals in the general population without a notable deviation in the GHIGF- 1 axis functioning. In addition, over t...
Source: Current Vascular Pharmacology - November 14, 2023 Category: Drugs & Pharmacology Authors: Herman R Janez A Mikhailidis Dp Poredos P Blinc A Sabovic M Bajuk Studen K Schernthaner Gh Anagnostis P Antignani Pl Jensterle M Source Type: research
Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency
Curr Vasc Pharmacol. 2023 Nov 13. doi: 10.2174/0115701611269162231106042956. Online ahead of print.ABSTRACTGrowth hormone (GH) and insulin-like growth factor 1 (IGF-1) are increasingly recognised for their role in cardiovascular (CV) physiology. The GH-IGF-1 axis plays an essential role in the development of the CV system as well as in the complex molecular network that regulates cardiac and endothelial structure and function. A considerable correlation between GH levels and CV mortality exists even among individuals in the general population without a notable deviation in the GHIGF- 1 axis functioning. In addition, over t...
Source: Current Vascular Pharmacology - November 14, 2023 Category: Drugs & Pharmacology Authors: Herman R Janez A Mikhailidis Dp Poredos P Blinc A Sabovic M Bajuk Studen K Schernthaner Gh Anagnostis P Antignani Pl Jensterle M Source Type: research
Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency
Curr Vasc Pharmacol. 2023 Nov 13. doi: 10.2174/0115701611269162231106042956. Online ahead of print.ABSTRACTGrowth hormone (GH) and insulin-like growth factor 1 (IGF-1) are increasingly recognised for their role in cardiovascular (CV) physiology. The GH-IGF-1 axis plays an essential role in the development of the CV system as well as in the complex molecular network that regulates cardiac and endothelial structure and function. A considerable correlation between GH levels and CV mortality exists even among individuals in the general population without a notable deviation in the GHIGF- 1 axis functioning. In addition, over t...
Source: Current Vascular Pharmacology - November 14, 2023 Category: Drugs & Pharmacology Authors: Herman R Janez A Mikhailidis Dp Poredos P Blinc A Sabovic M Bajuk Studen K Schernthaner Gh Anagnostis P Antignani Pl Jensterle M Source Type: research
The experience of diagnosis announcement in rare endocrine diseases: a survey of the French FIRENDO network
CONCLUSION: This work suggests that better knowledge of the patient's experience is useful for improving the diagnosis announcement of rare endocrine disorders. The main recommendations derived from the survey were the need for several announcement visits, information on patient support groups and reference centers, imperatively avoiding impersonal announcement, and the usefulness of a written accompanying document.PMID:37951412 | DOI:10.1016/j.ando.2023.10.008 (Source: Annales d'Endocrinologie)
Source: Annales d'Endocrinologie - November 11, 2023 Category: Endocrinology Authors: Haifa Rahabi Maria Givony B éatrice Demaret Fr édérique Albarel Marie-Reine Aubron Beate Bart ès Lucie Bernard Hendy Abdoul Naim Bouazza Philippe Brun Delphine Drui V éronique Dujardin Catherine Lan çon Sabine Malivoir Ir ène Netchine B énédicte Source Type: research
The experience of diagnosis announcement in rare endocrine diseases: a survey of the French FIRENDO network
CONCLUSION: This work suggests that better knowledge of the patient's experience is useful for improving the diagnosis announcement of rare endocrine disorders. The main recommendations derived from the survey were the need for several announcement visits, information on patient support groups and reference centers, imperatively avoiding impersonal announcement, and the usefulness of a written accompanying document.PMID:37951412 | DOI:10.1016/j.ando.2023.10.008 (Source: Annales d'Endocrinologie)
Source: Annales d'Endocrinologie - November 11, 2023 Category: Endocrinology Authors: Haifa Rahabi Maria Givony B éatrice Demaret Fr édérique Albarel Marie-Reine Aubron Beate Bart ès Lucie Bernard Hendy Abdoul Naim Bouazza Philippe Brun Delphine Drui V éronique Dujardin Catherine Lan çon Sabine Malivoir Ir ène Netchine B énédicte Source Type: research
The experience of diagnosis announcement in rare endocrine diseases: a survey of the French FIRENDO network
CONCLUSION: This work suggests that better knowledge of the patient's experience is useful for improving the diagnosis announcement of rare endocrine disorders. The main recommendations derived from the survey were the need for several announcement visits, information on patient support groups and reference centers, imperatively avoiding impersonal announcement, and the usefulness of a written accompanying document.PMID:37951412 | DOI:10.1016/j.ando.2023.10.008 (Source: Annales d'Endocrinologie)
Source: Annales d'Endocrinologie - November 11, 2023 Category: Endocrinology Authors: Haifa Rahabi Maria Givony B éatrice Demaret Fr édérique Albarel Marie-Reine Aubron Beate Bart ès Lucie Bernard Hendy Abdoul Naim Bouazza Philippe Brun Delphine Drui V éronique Dujardin Catherine Lan çon Sabine Malivoir Ir ène Netchine B énédicte Source Type: research
The experience of diagnosis announcement in rare endocrine diseases: a survey of the French FIRENDO network
CONCLUSION: This work suggests that better knowledge of the patient's experience is useful for improving the diagnosis announcement of rare endocrine disorders. The main recommendations derived from the survey were the need for several announcement visits, information on patient support groups and reference centers, imperatively avoiding impersonal announcement, and the usefulness of a written accompanying document.PMID:37951412 | DOI:10.1016/j.ando.2023.10.008 (Source: Annales d'Endocrinologie)
Source: Annales d'Endocrinologie - November 11, 2023 Category: Endocrinology Authors: Haifa Rahabi Maria Givony B éatrice Demaret Fr édérique Albarel Marie-Reine Aubron Beate Bart ès Lucie Bernard Hendy Abdoul Naim Bouazza Philippe Brun Delphine Drui V éronique Dujardin Catherine Lan çon Sabine Malivoir Ir ène Netchine B énédicte Source Type: research
The experience of diagnosis announcement in rare endocrine diseases: a survey of the French FIRENDO network
CONCLUSION: This work suggests that better knowledge of the patient's experience is useful for improving the diagnosis announcement of rare endocrine disorders. The main recommendations derived from the survey were the need for several announcement visits, information on patient support groups and reference centers, imperatively avoiding impersonal announcement, and the usefulness of a written accompanying document.PMID:37951412 | DOI:10.1016/j.ando.2023.10.008 (Source: Annales d'Endocrinologie)
Source: Annales d'Endocrinologie - November 11, 2023 Category: Endocrinology Authors: Haifa Rahabi Maria Givony B éatrice Demaret Fr édérique Albarel Marie-Reine Aubron Beate Bart ès Lucie Bernard Hendy Abdoul Naim Bouazza Philippe Brun Delphine Drui V éronique Dujardin Catherine Lan çon Sabine Malivoir Ir ène Netchine B énédicte Source Type: research
The experience of diagnosis announcement in rare endocrine diseases: a survey of the French FIRENDO network
CONCLUSION: This work suggests that better knowledge of the patient's experience is useful for improving the diagnosis announcement of rare endocrine disorders. The main recommendations derived from the survey were the need for several announcement visits, information on patient support groups and reference centers, imperatively avoiding impersonal announcement, and the usefulness of a written accompanying document.PMID:37951412 | DOI:10.1016/j.ando.2023.10.008 (Source: Annales d'Endocrinologie)
Source: Annales d'Endocrinologie - November 11, 2023 Category: Endocrinology Authors: Haifa Rahabi Maria Givony B éatrice Demaret Fr édérique Albarel Marie-Reine Aubron Beate Bart ès Lucie Bernard Hendy Abdoul Naim Bouazza Philippe Brun Delphine Drui V éronique Dujardin Catherine Lan çon Sabine Malivoir Ir ène Netchine B énédicte Source Type: research
The experience of diagnosis announcement in rare endocrine diseases: a survey of the French FIRENDO network
CONCLUSION: This work suggests that better knowledge of the patient's experience is useful for improving the diagnosis announcement of rare endocrine disorders. The main recommendations derived from the survey were the need for several announcement visits, information on patient support groups and reference centers, imperatively avoiding impersonal announcement, and the usefulness of a written accompanying document.PMID:37951412 | DOI:10.1016/j.ando.2023.10.008 (Source: Annales d'Endocrinologie)
Source: Annales d'Endocrinologie - November 11, 2023 Category: Endocrinology Authors: Haifa Rahabi Maria Givony B éatrice Demaret Fr édérique Albarel Marie-Reine Aubron Beate Bart ès Lucie Bernard Hendy Abdoul Naim Bouazza Philippe Brun Delphine Drui V éronique Dujardin Catherine Lan çon Sabine Malivoir Ir ène Netchine B énédicte Source Type: research
The experience of diagnosis announcement in rare endocrine diseases: A survey of the French FIRENDO network
CONCLUSION: This work suggests that better knowledge of the patient's experience is useful for improving the diagnosis announcement of rare endocrine disorders. The main recommendations derived from the survey were the need for several announcement visits, information on patient support groups and reference centers, imperatively avoiding impersonal announcement, and the usefulness of a written accompanying document.PMID:37951412 | DOI:10.1016/j.ando.2023.10.008 (Source: Annales d'Endocrinologie)
Source: Annales d'Endocrinologie - November 11, 2023 Category: Endocrinology Authors: Haifa Rahabi Maria Givony B éatrice Demaret Fr édérique Albarel Marie-Reine Aubron Beate Bart ès Lucie Bernard Hendy Abdoul Naim Bouazza Philippe Brun Delphine Drui V éronique Dujardin Catherine Lan çon Sabine Malivoir Ir ène Netchine B énédicte Source Type: research
